BNTCNasdaqPharmaceutical PreparationsFiscal year ends June 30
Benitec Biopharma Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 14, 2026
$8.36+0.25 (+3.08%)
Close on Oct 19, 2026
- Market cap
- $413.29M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$7.29 (−46.58%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $413.29M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 2.33
- Dividend yield
- –
- Free cash flow yield
- -4.02%
Fundamentals
- Net income
- -$45.55M
- EPS, diluted
- -$0.98
- Free cash flow
- -$16.62M
- Book value per share
- $3.58
- Diluted shares
- 49M
Nine years at a glance
Fiscal years 2018 to 2026, USD
Revenue
–
Operating income
-$51.19M
Net income
-$45.55M
EPS, diluted
-$0.98
Free cash flow
-$16.62M
Reported period